Publication | Open Access
Evaluating the diagnostic and prognostic value of serum <scp>TuM2‐PK</scp>, <scp>NSE,</scp> and <scp>ProGRP</scp> in small cell lung cancer
18
Citations
14
References
2023
Year
These results suggest that TuM2-PK levels in the serum could be an effective biomarker for the diagnosis and prognosis of SCLC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1